Physician profile
Thomas W Morris
NPI 1457641664
$2,963.73
in general payments reported to CMS, 2019-2025
10 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,083 · 2022: $263 · 2023: $123 · 2024: $138 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap, INC. | $2,023.58 | 2019 | |
| Depuy Synthes Sales INC. | $232.04 | 2022-2023 | Fibergraft Bg Morsels, Viper, Teligen |
| Medtronic, INC. | $158.67 | 2025 | Mazor X System |
| Zimvie INC. | $137.69 | 2024 | |
| Globus Medical, INC. | $111.09 | 2022 | |
| Gt Medical Technologies, INC | $88.50 | 2025 | Gammatile |
| Cerapedics INC. | $79.59 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic USA, INC. | $59.41 | 2019 | |
| Innovation Technologies INC | $43.42 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $29.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.